BDX

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Dollar change -0.25
Percentage change -0.11	%

Peers: JNJ ABT DHR BAX TMO ISRG HOLX BSX ALGN XRAY

| Held by: VTI VOO SPY IVV VTV XLV VIG VHT IHI IWD

Index	S&P 500	P/E	37.14	EPS (ttm)	6.02	Insider Own	0.20%	Shs Outstand	287.14M	Perf Week	-0.79%
Market Cap	64.19B	Forward P/E	14.29	EPS next Y	15.65	Insider Trans	-2.42%	Shs Float	286.57M	Perf Month	-2.59%
Income	1.75B	PEG	4.14	EPS next Q	3.28	Inst Own	92.72%	Short Float	1.02%	Perf Quarter	0.25%
Sales	20.64B	P/S	3.11	EPS this Y	9.72%	Inst Trans	1.91%	Short Ratio	1.43	Perf Half Y	-5.14%
Book/sh	87.78	P/B	2.55	EPS next Y	8.53%	ROA	3.27%	Short Interest	2.94M	Perf Year	-6.65%
Cash/sh	2.89	P/C	77.34	EPS next 5Y	8.97%	ROE	6.92%	52W Range	218.75 - 251.99	Perf YTD	-1.45%
Dividend Est.	3.88 (1.74%)	P/FCF	21.86	EPS past 5Y	8.27%	ROI	4.10%	52W High	-11.28%	Beta	0.37
Dividend TTM	3.98 (1.78%)	Quick Ratio	0.63	Sales past 5Y	4.72%	Gross Margin	45.35%	52W Low	2.20%	ATR (14)	4.65
Dividend Ex-Date	Mar 10, 2025	Current Ratio	1.13	EPS Y/Y TTM	42.05%	Oper. Margin	14.13%	RSI (14)	41.05	Volatility	2.44% 1.85%
Employees	74000	Debt/Eq	0.74	Sales Y/Y TTM	5.89%	Profit Margin	8.47%	Recom	1.58	Target Price	271.00
Option/Short	Yes / Yes	LT Debt/Eq	0.69	EPS Q/Q	8.20%	Payout	64.86%	Rel Volume	0.87	Prev Close	223.82
Sales Surprise	1.33%	EPS Surprise	15.18%	Sales Q/Q	9.82%	Earnings	Feb 06 BMO	Avg Volume	2.05M	Price	223.57
SMA20	-1.23%	SMA50	-3.84%	SMA200	-3.98%	Trades		Volume	1,504,151	Change	-0.11%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-01-24	Upgrade	Citigroup	Neutral → Buy	$255 → $275
May-30-24	Initiated	Goldman	Buy	$274
Jul-24-23	Upgrade	Raymond James	Mkt Perform → Outperform	$305
May-30-23	Resumed	Morgan Stanley	Overweight	$295
May-05-23	Upgrade	Piper Sandler	Neutral → Overweight	$260 → $290
Apr-12-23	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$304
Jan-03-23	Upgrade	BofA Securities	Neutral → Buy	$250 → $290
Dec-12-22	Upgrade	Citigroup	Sell → Neutral	$221 → $250
Jul-11-22	Downgrade	Citigroup	Neutral → Sell	$265 → $235
Jun-24-22	Upgrade	Wells Fargo	Equal Weight → Overweight	$275
Mar-18-22	Resumed	Raymond James	Mkt Perform
Mar-02-22	Resumed	BofA Securities	Neutral	$290
Dec-08-21	Downgrade	Piper Sandler	Overweight → Neutral	$285 → $260
Aug-06-21	Downgrade	JP Morgan	Overweight → Neutral	$265
May-25-21	Initiated	Barclays	Equal Weight	$270
Dec-15-20	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$297
Dec-15-20	Downgrade	Wells Fargo	Overweight → Equal Weight	$265
Jul-09-20	Upgrade	Barclays	Equal Weight → Overweight	$300
Jun-01-20	Resumed	Goldman	Buy	$278
Mar-05-20	Initiated	Citigroup	Neutral	$260

Show Previous Ratings

Mar-10-25 05:06AM	BD (NYSE:BDX): Strongest Q4 Results from the Surgical Equipment & Consumables - Diversified Group (StockStory)
Feb-28-25 09:45AM	Here's Why Becton Dickinson (BDX) is a Strong Growth Stock (Zacks)
04:07AM	3 Reasons to Sell BDX and 1 Stock to Buy Instead (StockStory)
Feb-27-25 09:40AM	Why Becton Dickinson (BDX) is a Top Value Stock for the Long-Term (Zacks)
Feb-20-25 05:23AM	BD business separation could allow competitors to rise in IVD test markets (Medical Device Network)
08:30AM	Loading…
Feb-18-25 08:30AM	Do Options Traders Know Something About BD (BDX) Stock We Don't? (Zacks)
Feb-13-25 04:15PM	BD to Present at Investor Healthcare Conferences (PR Newswire)
Feb-12-25 09:45AM	Why Becton Dickinson (BDX) is a Top Growth Stock for the Long-Term (Zacks)
Feb-07-25 12:43PM	BD business split may prefigure life sciences division selloff (Medical Device Network)
09:30AM	Becton Dickinson price target raised to $269 from $265 at BofA (TipRanks)
02:07AM	Becton Dickinson & Co (BDX) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
12:08AM	Q1 2025 Becton Dickinson and Co Earnings Call (Thomson Reuters StreetEvents)
Feb-06-25 01:50PM	Becton Dickinson to Separate Biosciences and Diagnostic Solutions Business (GuruFocus.com) -7.28%
12:31PM	Analyst Report: Becton, Dickinson and Company (Morningstar Research)
10:24AM	Becton Dickinson Q1 Earnings: Revenue And EPS Beat, Lowers Outlook, Outlines Intent To Separate Biosciences And Diagnostic Solutions Business (Benzinga)
06:30PM	Loading…
Feb-05-25 06:30PM	Compared to Estimates, Becton Dickinson (BDX) Q1 Earnings: A Look at Key Metrics (Zacks)
05:55PM	Becton Dickinson (BDX) Tops Q1 Earnings and Revenue Estimates (Zacks)
05:02PM	Becton Dickinson to Separate From Bioscience and Diagnostic Solutions Business (The Wall Street Journal)
04:49PM	Becton Dickinson: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
04:30PM	BD Reports First Quarter Fiscal 2025 Financial Results (PR Newswire)
04:30PM	BD Announces Intent to Separate Biosciences and Diagnostic Solutions Business to Enhance Focus, Drive Growth and Unlock Value (PR Newswire)
08:07AM	BD (BDX) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
Feb-03-25 09:16AM	Insights Into Becton Dickinson (BDX) Q1: Wall Street Projections for Key Metrics (Zacks)
09:09AM	Analyst Report: Becton, Dickinson and Company (Morningstar Research)
Jan-30-25 10:01AM	Becton Dickinson (BDX) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Jan-28-25 04:15PM	BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; BD Completed $750 Million Repurchase to Date in FY25 (PR Newswire)
05:30AM	DEI Pay Incentives Come Under Pressure After Two-Year Surge (The Wall Street Journal)
Jan-24-25 12:27PM	Alphabet, Uber, Applied Materials, and 19 Other Picks From the Barrons Roundtable (Barrons.com)
Jan-23-25 07:15AM	BD and Biosero Collaborate to Enable Robotic Integration with Flow Cytometers Used in Drug Discovery and Development (PR Newswire)
Jan-22-25 11:07AM	Carilion to use BDs needle-free blood draw device (Medical Device Network)
06:50AM	Loading…
06:50AM	Carilion Clinic First in Virginia to Offer Needle-free In-patient Blood Draws, Redefining Patient Standard of Care (PR Newswire)
Jan-21-25 05:22PM	Masimo Taps Katie Szyman as Permanent CEO (The Wall Street Journal)
Jan-16-25 04:15PM	BD to Announce Financial Results for its First Quarter of Fiscal 2025 (PR Newswire)
Jan-15-25 08:56AM	Is Becton, Dickinson and Company (BDX) an Undervalued Stock? (Insider Monkey)
06:50AM	New Survey Reveals Nearly 3 in 4 Canadian Women Are Delaying Their OB/GYN Exams, Increasing Risks for Cervical Cancer (PR Newswire)
06:50AM	BD Boosts U.S. Manufacturing of Critical Medical Devices (PR Newswire)
Jan-14-25 02:06PM	3 in 4 women are skipping a routine appointment and putting themselves at higher risk for cancer (Fortune)
Jan-13-25 06:50AM	New ASCCP Guidelines Include More Precise Method of Cervical Cancer Screening (PR Newswire)
Jan-10-25 09:44AM	The Forgotten Four (GuruFocus.com)
06:50AM	BD Names Pamela Spikner as Chief Accounting Officer and Controller (PR Newswire)
Jan-09-25 09:45AM	Here's Why Becton Dickinson (BDX) is a Strong Growth Stock (Zacks)
06:50AM	New Survey Finds Women Are Skipping Their OB/GYN Exams, Increasing Risks for Cervical Cancer (PR Newswire)
Jan-07-25 04:15PM	BD To Host Virtual 2025 Annual Meeting of Shareholders (PR Newswire)
12:10PM	Will Becton Dickinson (BDX) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Jan-03-25 09:40AM	Becton Dickinson (BDX) is a Top-Ranked Value Stock: Should You Buy? (Zacks)
Dec-20-24 09:45AM	Why Becton Dickinson (BDX) is a Top Growth Stock for the Long-Term (Zacks)
Dec-18-24 09:40AM	Here's Why Becton Dickinson (BDX) is a Strong Value Stock (Zacks)
06:18AM	BD and Babson expand fingertip blood testing across US health systems (Medical Device Network)
Dec-17-24 09:50AM	Why Becton Dickinson (BDX) is a Top Momentum Stock for the Long-Term (Zacks)
06:50AM	BD and Babson Diagnostics Launch Innovative Fingertip Blood Testing to Health Care Organizations (PR Newswire)
Dec-16-24 05:52PM	Becton Dickinson to Pay $175 Million to Settle SEC Probe (Bloomberg)
04:46PM	Becton Dickinson settles charges over infusion pump risks, SEC says (Reuters)
04:32PM	BD Resolves Previously Disclosed SEC Investigation (PR Newswire)
08:08AM	Heres Why Matrix Asset Advisors Added Becton, Dickinson and Company (BDX) (Insider Monkey)
Dec-14-24 06:19AM	These 10 most-loved S&P 500 stocks could see as much as 50% upside in 2025 (MarketWatch)
12:10AM	Why Is Becton, Dickinson and Company (BDX) Among the Best Income Stocks to Buy According to Analysts? (Insider Monkey)
Dec-05-24 04:05PM	Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors (GlobeNewswire)
Dec-02-24 02:21PM	Why Becton Dickinson (BDX) is a Top Value Stock for the Long-Term (Zacks)
Nov-26-24 01:15PM	Becton Dickinson Spinoff Embecta Stops Insulin Patch Pump Program, Plans Restructuring, Stock Jumps (Benzinga)
Nov-20-24 02:15PM	First of Its Kind HPV Self-Collection Study Launched to Improve Cervical Cancer Screening in Underserved Communities (PR Newswire)
Nov-19-24 04:15PM	BD to Present at the 7th Annual Evercore ISI HealthCONx Conference (PR Newswire)
Nov-12-24 01:02PM	First Eagle Investment Bolsters Stake in Becton Dickinson & Co in Q3 2024 (GuruFocus.com)
Nov-11-24 09:40AM	Are Investors Undervaluing Becton, Dickinson and Company (BDX) Right Now? (Zacks)
Nov-08-24 02:07AM	Becton Dickinson & Co (BDX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
Nov-07-24 11:56PM	Q4 2024 Becton Dickinson and Co Earnings Call (Thomson Reuters StreetEvents) -5.39%
01:18PM	Global Medical Tech Becton, Dickinson Expects Lower China Sales, Bioscience And Pharma Market Dynamics To Impact 2025 Organic Revenue Growth (Benzinga)
12:45PM	Looking for a Growth Stock? 3 Reasons Why Becton Dickinson (BDX) is a Solid Choice (Zacks)
10:13AM	Analyst Report: Becton, Dickinson and Company (Morningstar Research)
09:30AM	Becton Dickinson (BDX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
07:45AM	Becton Dickinson (BDX) Q4 Earnings and Revenues Surpass Estimates (Zacks)
06:52AM	Becton Dickinson: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
06:30AM	BD Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results (PR Newswire)
06:25AM	BD Board Increases Dividend for 53rd Consecutive Year (PR Newswire)
Nov-04-24 09:16AM	Insights Into Becton Dickinson (BDX) Q4: Wall Street Projections for Key Metrics (Zacks)
Nov-03-24 01:37PM	Becton, Dickinson and Company (BDX): Expanding Innovations in Medical Technology (Insider Monkey)
Oct-31-24 10:01AM	Becton Dickinson (BDX) Earnings Expected to Grow: Should You Buy? (Zacks)
Oct-30-24 09:40AM	Here's Why Becton Dickinson (BDX) is a Strong Value Stock (Zacks)
06:50AM	BD Launches Enhanced Intraosseous System, Enabling Vascular Access in Seconds for Critical Care Situations (PR Newswire)
06:05AM	BDs Onclarity HPV Assay receives Health Canada approval (Medical Device Network)
Oct-29-24 09:45AM	Here's Why Becton Dickinson (BDX) is a Strong Growth Stock (Zacks)
06:50AM	Women in Canada Can Now Collect Their Own Sample at Home for Cervical Cancer Screening (PR Newswire)
Oct-25-24 06:53AM	BD Named Among the 100 Best Corporate Citizens of 2024 (PR Newswire)
Oct-22-24 12:45PM	3 Reasons Why Becton Dickinson (BDX) Is a Great Growth Stock (Zacks)
Oct-15-24 05:07AM	BD launches automated, robotics-compatible reagent kits (Medical Device Network)
Oct-14-24 09:40AM	Why Becton Dickinson (BDX) is a Top Value Stock for the Long-Term (Zacks)
06:45AM	BD Announces New Robotics Solution to Automate, Standardize Single-Cell Research (PR Newswire)
Oct-11-24 12:10PM	Will Becton Dickinson (BDX) Beat Estimates Again in Its Next Earnings Report? (Zacks)
09:45AM	Why Becton Dickinson (BDX) is a Top Growth Stock for the Long-Term (Zacks)
Oct-10-24 07:21PM	Is Becton, Dickinson and Company (NYSE:BDX) The Most Popular Stock Among Mutual Funds According To Goldman Sachs? (Insider Monkey)
04:15PM	BD to Announce its Fiscal 2024 Fourth Quarter and Full Year Financial Results (PR Newswire)
Oct-07-24 09:50AM	Here's Why Becton Dickinson (BDX) is a Strong Momentum Stock (Zacks)
Oct-03-24 05:05PM	Becton Dickinson in pact to to resolve vast majority of hernia litigation (TipRanks)
Oct-02-24 05:00PM	BD Reaches Agreement to Resolve Vast Majority of Hernia Litigation (PR Newswire)
08:40AM	Becton Dickinson target raised, added to Tactical Outperform list at Evercore (TipRanks)
Sep-26-24 06:50AM	New Data Reveals BD's Artificial Intelligence Software Highly Effective in Detecting Indicators of Controlled Substance Diversion (PR Newswire)
Sep-25-24 04:05PM	PreAnalytiX, a QIAGEN and BD joint venture, launches novel solution for liquid biopsy from urine samples (GlobeNewswire)
Sep-18-24 06:50AM	BD Expands Capacity for Advanced Prefillable Syringes and Enhances Injection Experience for the Next Generation of Biologics (PR Newswire)
Sep-10-24 09:40AM	Here's Why Becton Dickinson (BDX) is a Strong Value Stock (Zacks)
Sep-09-24 09:45AM	Here's Why Becton Dickinson (BDX) is a Strong Growth Stock (Zacks)
Sep-04-24 05:32AM	BD completes acquisition of Edwards Lifesciences Critical Care product group (Medical Device Network)

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, instruments, and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, ambulatory surgery centers, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Byrd Richard	EVP & President Interventional	Mar 12 '25	Sale	224.91	1,940	436,325	7,411	Mar 13 01:03 PM
RICHARD BYRD	Officer	Mar 12 '25	Proposed Sale	224.92	1,940	436,345		Mar 12 04:22 PM
SCOTT BERTRAM L	Director	Feb 12 '25	Sale	227.99	700	159,593	36,033	Feb 12 04:44 PM
BERTRAM SCOTT	Director	Feb 12 '25	Proposed Sale	227.99	700	159,593		Feb 12 04:12 PM
Henderson Jeffrey William	Director	Feb 10 '25	Buy	233.62	1,500	350,430	8,015	Feb 10 05:03 PM
Shan David	EVP and Chief ISC Officer	Jan 21 '25	Sale	240.00	500	120,000	5,741	Jan 22 09:19 AM
Neal Shana Carol	EVP and Chief People Officer	Jan 21 '25	Sale	240.00	787	188,880	15,414	Jan 22 09:18 AM
SHANA NEAL	Officer	Jan 21 '25	Proposed Sale	237.38	787	186,818		Jan 21 04:21 PM
DAVID SHAN	Officer	Jan 21 '25	Proposed Sale	237.38	500	118,690		Jan 21 01:47 PM
Garrison Michael David	EVP & President, Medical	Jan 17 '25	Sale	236.51	597	141,196	5,544	Jan 21 08:21 AM
MICHAEL GARRISON	Officer	Jan 17 '25	Proposed Sale	236.30	597	141,071		Jan 17 04:20 PM
Neal Shana Carol	EVP and Chief People Officer	Nov 21 '24	Option Exercise	0.00	111	0	17,021	Jan 10 07:11 AM
Neal Shana Carol	EVP and Chief People Officer	Jan 07 '25	Sale	235.00	788	185,180	16,201	Jan 10 07:11 AM
SHANA NEAL	Officer	Jan 07 '25	Proposed Sale	230.70	788	181,792		Jan 07 04:19 PM
Garrison Michael David	EVP & President, Medical	Dec 19 '24	Sale	223.33	2,838	633,811	6,141	Dec 20 10:18 AM
MICHAEL GARRISON	Officer	Dec 19 '24	Proposed Sale	224.09	2,838	635,967		Dec 19 04:20 PM
Goette Roland	EVP and President, EMEA	Dec 06 '24	Option Exercise	157.30	13,334	2,097,403	28,828	Dec 10 08:23 PM
Goette Roland	EVP and President, EMEA	Dec 06 '24	Sale	221.01	4,483	990,788	24,345	Dec 10 08:23 PM
Goette Roland	EVP and President, EMEA	Dec 09 '24	Sale	219.03	638	139,741	14,217	Dec 10 08:23 PM
Neal Shana Carol	EVP and Chief People Officer	Dec 06 '24	Sale	220.49	1,000	220,490	16,989	Dec 10 08:17 PM
ROLAND GOETTE	Officer	Dec 09 '24	Proposed Sale	220.02	638	140,373		Dec 09 04:47 PM
Shan David	EVP and Chief ISC Officer	Dec 05 '24	Sale	220.25	1,500	330,375	6,285	Dec 06 04:55 PM
ROLAND GOETTE	Officer	Dec 06 '24	Proposed Sale	222.24	4,483	996,302		Dec 06 04:31 PM
SHANA NEAL	Officer	Dec 06 '24	Proposed Sale	222.24	1,000	222,240		Dec 06 04:31 PM
DAVID SHAN	Officer	Dec 05 '24	Proposed Sale	221.43	1,500	332,145		Dec 05 04:42 PM
BURZIK CATHERINE M	Director	Sep 16 '24	Proposed Sale	235.78	400	94,312		Sep 16 11:52 AM
Goette Roland	EVP and President EMEA	Aug 14 '24	Option Exercise	132.54	5,295	701,799	16,603	Aug 15 01:47 PM
Spoerel Thomas J	SVP,Controller&Chief Acct Off	Jun 10 '24	Sale	239.31	300	71,793	1,976	Jun 11 01:45 PM
Goette Roland	EVP and President EMEA	May 15 '24	Sale	236.73	3,300	781,224	11,308	May 16 07:54 PM
Goette Roland	EVP and President EMEA	May 13 '24	Sale	236.70	3,300	781,121	14,608	May 15 02:44 PM
Garrison Michael David	EVP & President Medical	Apr 30 '24	Sale	232.81	1,715	399,269	5,381	May 01 12:59 PM
Spoerel Thomas J	SVP,Controller&Chief Acct Off	Mar 14 '24	Sale	238.29	282	67,198	2,276	Mar 15 02:19 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Becton Dickinson & Co

Upgrade your FINVIZ experience